July 29, 2019
Weil’s global Litigation Department delivered four significant victories last week, implicating hundreds of millions of dollars in claims and demonstrating Weil’s prowess across practices, courts and offices.
To open the week, on Monday, July 22, a Weil Securities Litigation team secured a major appellate win for Willis when the Fifth Circuit affirmed a $120 million settlement that Weil designed, resolving allegations in an MDL that Willis fraudulently induced investments in the Stanford Ponzi scheme – the second-biggest Ponzi scheme in history after Madoff. Litigation Department Co-Chair Jonathan Polkes led the Weil team, which included partners Josh Amsel and Greg Silbert, as well as associate David Fitzmaurice, all based in New York. Read more about this win.
On Wednesday, July 24, a Weil Complex Commercial Litigation team based in Miami won its second consecutive victory for Dometic in a consolidated consumer class action in U.S. District Court for the Southern District of Florida alleging that the cooling units in various models of the company’s gas absorption refrigerators purportedly contained a latent defect. After winning summary judgment two years ago in a predecessor case, the Weil team defeated the plaintiffs’ motion to certify a class, resulting in the complete dismissal of all claims. The Weil team was led by Edward Soto, Co-Head of Weil’s national Complex Commercial Litigation practice and Managing Partner of the Firm’s Miami office, and included associates Pravin Patel, Corey Brady, Lara Bach, and Brian Liegel (as well as former Weil colleague Erica Rutner, who served as co-counsel). Read more about the victory.
Also on Wednesday, a Weil Patent Litigation team based in Silicon Valley and Washington, D.C. obtained its second victory in as many weeks for Bio-Rad Laboratories and the University of Chicago in a high-profile patent dispute brought against a competitor, 10X Genomics. Following a July 9 decision by a Delaware federal judge that upheld our clients’ $24 million jury trial victory in November 2018, Weil won a permanent injunction that prohibits 10X from manufacturing or selling a number of key products that infringe the patents-in-suit. The Weil team was led by Ed Reines, Co-Head of both Weil's Patent Litigation practice and its Life Sciences practice, and partner Derek Walter, and included counsel Robert Vlasis and associates Amanda Branch, Chris Lavin and Kathryn Culver. Read more about this win.
Finally, on Thursday, July 25, another Weil Securities Litigation team secured another major win for Willis, defeating a stockholder class action in Delaware Chancery Court arising out of the 2016 $18 billion “merger of equals” between Willis Group and Towers Watson – one of several cases Weil has been defending for Willis Towers Watson in connection with this transaction, including a securities class action in the U.S. District Court for the Eastern District of Virginia that Weil won on a motion to dismiss in July 2018. The Weil team was led by John Neuwirth, Co-Head of Weil’s Securities Litigation practice, and included partner Josh Amsel and associates Matthew Connors, Amanda Pooler and Sean Moloney. Read more about the victory.